<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1990-08-01" modified="2020-10-07" version="195">
<accession>P17181</accession>
<accession>B2R6L9</accession>
<accession>B4DNT3</accession>
<accession>D3DSF0</accession>
<accession>Q53GW9</accession>
<accession>Q53H11</accession>
<accession>Q6PKD7</accession>
<accession>Q7M4L2</accession>
<accession>Q8WTZ2</accession>
<name>INAR1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Interferon alpha/beta receptor 1</fullName>
<shortName>IFN-R-1</shortName>
<shortName>IFN-alpha/beta receptor 1</shortName>
</recommendedName>
<alternativeName>
<fullName>Cytokine receptor class-II member 1</fullName>
</alternativeName>
<alternativeName>
<fullName>Cytokine receptor family 2 member 1</fullName>
<shortName>CRF2-1</shortName>
</alternativeName>
<alternativeName>
<fullName>Type I interferon receptor 1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">IFNAR1</name>
<name type="synonym">IFNAR</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1990" name="Cell" volume="60" first="225" last="234">
<title>Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA.</title>
<authorList>
<person name="Uze G."/>
<person name="Lutfalla G."/>
<person name="Gresser I."/>
</authorList>
<dbReference type="PubMed" id="2153461"/>
<dbReference type="DOI" id="10.1016/0092-8674(90)90738-z"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANT LEU-168</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1992" name="J. Biol. Chem." volume="267" first="2802" last="2809">
<title>The structure of the human interferon alpha/beta receptor gene.</title>
<authorList>
<person name="Lutfalla G."/>
<person name="Gardiner K."/>
<person name="Proudhon D."/>
<person name="Vielh E."/>
<person name="Uze G."/>
</authorList>
<dbReference type="PubMed" id="1370833"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT LEU-168</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4)</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="4">
<citation type="submission" date="2005-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Suzuki Y."/>
<person name="Sugano S."/>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Takeda T."/>
<person name="Sakaki Y."/>
<person name="Tanaka A."/>
<person name="Yokoyama S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANT LEU-168</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2004-06" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="SeattleSNPs variation discovery resource"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS ILE-307 AND MET-359</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2000" name="Nature" volume="405" first="311" last="319">
<title>The DNA sequence of human chromosome 21.</title>
<authorList>
<person name="Hattori M."/>
<person name="Fujiyama A."/>
<person name="Taylor T.D."/>
<person name="Watanabe H."/>
<person name="Yada T."/>
<person name="Park H.-S."/>
<person name="Toyoda A."/>
<person name="Ishii K."/>
<person name="Totoki Y."/>
<person name="Choi D.-K."/>
<person name="Groner Y."/>
<person name="Soeda E."/>
<person name="Ohki M."/>
<person name="Takagi T."/>
<person name="Sakaki Y."/>
<person name="Taudien S."/>
<person name="Blechschmidt K."/>
<person name="Polley A."/>
<person name="Menzel U."/>
<person name="Delabar J."/>
<person name="Kumpf K."/>
<person name="Lehmann R."/>
<person name="Patterson D."/>
<person name="Reichwald K."/>
<person name="Rump A."/>
<person name="Schillhabel M."/>
<person name="Schudy A."/>
<person name="Zimmermann W."/>
<person name="Rosenthal A."/>
<person name="Kudoh J."/>
<person name="Shibuya K."/>
<person name="Kawasaki K."/>
<person name="Asakawa S."/>
<person name="Shintani A."/>
<person name="Sasaki T."/>
<person name="Nagamine K."/>
<person name="Mitsuyama S."/>
<person name="Antonarakis S.E."/>
<person name="Minoshima S."/>
<person name="Shimizu N."/>
<person name="Nordsiek G."/>
<person name="Hornischer K."/>
<person name="Brandt P."/>
<person name="Scharfe M."/>
<person name="Schoen O."/>
<person name="Desario A."/>
<person name="Reichelt J."/>
<person name="Kauer G."/>
<person name="Bloecker H."/>
<person name="Ramser J."/>
<person name="Beck A."/>
<person name="Klages S."/>
<person name="Hennig S."/>
<person name="Riesselmann L."/>
<person name="Dagand E."/>
<person name="Wehrmeyer S."/>
<person name="Borzym K."/>
<person name="Gardiner K."/>
<person name="Nizetic D."/>
<person name="Francis F."/>
<person name="Lehrach H."/>
<person name="Reinhardt R."/>
<person name="Yaspo M.-L."/>
</authorList>
<dbReference type="PubMed" id="10830953"/>
<dbReference type="DOI" id="10.1038/35012518"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
<tissue>Ovary</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1994" name="FEBS Lett." volume="338" first="295" last="300">
<title>Identification of mRNAs encoding two different soluble forms of the human interferon alpha-receptor.</title>
<authorList>
<person name="Abramovich C."/>
<person name="Ratovitski E."/>
<person name="Lundgren E."/>
<person name="Revel M."/>
</authorList>
<dbReference type="PubMed" id="8307198"/>
<dbReference type="DOI" id="10.1016/0014-5793(94)80287-4"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 398-514 (ISOFORM 3)</scope>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 419-557 (ISOFORM 2)</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>ALTERNATIVE SPLICING</scope>
<source>
<tissue>Myeloma</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="1994" name="Mol. Cell. Biol." volume="14" first="8133" last="8142">
<title>Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase.</title>
<authorList>
<person name="Colamonici O."/>
<person name="Yan H."/>
<person name="Domanski P."/>
<person name="Handa R."/>
<person name="Smalley D."/>
<person name="Mullersman J."/>
<person name="Witte M."/>
<person name="Krishnan K."/>
<person name="Krolewski J."/>
</authorList>
<dbReference type="PubMed" id="7526154"/>
<dbReference type="DOI" id="10.1128/mcb.14.12.8133"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-466 AND TYR-481 BY TYK2</scope>
<scope>INTERACTION WITH TYK2</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="21606" last="21611">
<title>Cloning and expression of a long form of the beta subunit of the interferon alpha beta receptor that is required for signaling.</title>
<authorList>
<person name="Domanski P."/>
<person name="Witte M."/>
<person name="Kellum M."/>
<person name="Rubinstein M."/>
<person name="Hackett R."/>
<person name="Pitha P."/>
<person name="Colamonici O.R."/>
</authorList>
<dbReference type="PubMed" id="7665574"/>
<dbReference type="DOI" id="10.1074/jbc.270.37.21606"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH IFNAR2</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1997" name="Mol. Cell. Biol." volume="17" first="2048" last="2056">
<title>Functional subdomains of STAT2 required for preassociation with the alpha interferon receptor and for signaling.</title>
<authorList>
<person name="Li X."/>
<person name="Leung S."/>
<person name="Kerr I.M."/>
<person name="Stark G.R."/>
</authorList>
<dbReference type="PubMed" id="9121453"/>
<dbReference type="DOI" id="10.1128/mcb.17.4.2048"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH STAT1 AND STAT2</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1999" name="Biochem. Biophys. Res. Commun." volume="255" first="539" last="544">
<title>Formation of a uniquely stable type I interferon receptor complex by interferon beta is dependent upon particular interactions between interferon beta and its receptor and independent of tyrosine phosphorylation.</title>
<authorList>
<person name="Russell-Harde D."/>
<person name="Wagner T.C."/>
<person name="Perez H.D."/>
<person name="Croze E."/>
</authorList>
<dbReference type="PubMed" id="10049744"/>
<dbReference type="DOI" id="10.1006/bbrc.1998.0105"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH IFNAR2</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2003" name="EMBO J." volume="22" first="5480" last="5490">
<title>SCF(HOS) ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-alpha receptor.</title>
<authorList>
<person name="Kumar K.G."/>
<person name="Tang W."/>
<person name="Ravindranath A.K."/>
<person name="Clark W.A."/>
<person name="Croze E."/>
<person name="Fuchs S.Y."/>
</authorList>
<dbReference type="PubMed" id="14532120"/>
<dbReference type="DOI" id="10.1093/emboj/cdg524"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH FBXW11</scope>
<scope>UBIQUITINATION</scope>
<scope>PHOSPHORYLATION AT SER-535</scope>
<scope>MUTAGENESIS OF SER-535</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="46614" last="46620">
<title>Phosphorylation and specific ubiquitin acceptor sites are required for ubiquitination and degradation of the IFNAR1 subunit of type I interferon receptor.</title>
<authorList>
<person name="Kumar K.G."/>
<person name="Krolewski J.J."/>
<person name="Fuchs S.Y."/>
</authorList>
<dbReference type="PubMed" id="15337770"/>
<dbReference type="DOI" id="10.1074/jbc.m407082200"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT SER-535</scope>
<scope>MUTAGENESIS OF LYS-501; 525-LYS-LYS-526; SER-535 AND SER-539</scope>
<scope>UBIQUITINATION</scope>
<scope>INTERACTION WITH FBXW11 AND TYK2</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2007" name="J. Cell Biol." volume="179" first="935" last="950">
<title>Site-specific ubiquitination exposes a linear motif to promote interferon-alpha receptor endocytosis.</title>
<authorList>
<person name="Kumar K.G."/>
<person name="Barriere H."/>
<person name="Carbone C.J."/>
<person name="Liu J."/>
<person name="Swaminathan G."/>
<person name="Xu P."/>
<person name="Li Y."/>
<person name="Baker D.P."/>
<person name="Peng J."/>
<person name="Lukacs G.L."/>
<person name="Fuchs S.Y."/>
</authorList>
<dbReference type="PubMed" id="18056411"/>
<dbReference type="DOI" id="10.1083/jcb.200706034"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>UBIQUITINATION</scope>
<scope>PHOSPHORYLATION AT SER-535</scope>
<scope>INTERACTION WITH FBXW11</scope>
<scope>MUTAGENESIS OF TYR-466</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="24328" last="24340">
<title>Palmitoylation of interferon-alpha (IFN-alpha) receptor subunit IFNAR1 is required for the activation of Stat1 and Stat2 by IFN-alpha.</title>
<authorList>
<person name="Claudinon J."/>
<person name="Gonnord P."/>
<person name="Beslard E."/>
<person name="Marchetti M."/>
<person name="Mitchell K."/>
<person name="Boularan C."/>
<person name="Johannes L."/>
<person name="Eid P."/>
<person name="Lamaze C."/>
</authorList>
<dbReference type="PubMed" id="19561067"/>
<dbReference type="DOI" id="10.1074/jbc.m109.021915"/>
</citation>
<scope>FUNCTION</scope>
<scope>PALMITOYLATION AT CYS-463</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="Nat. Biotechnol." volume="27" first="378" last="386">
<title>Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins.</title>
<authorList>
<person name="Wollscheid B."/>
<person name="Bausch-Fluck D."/>
<person name="Henderson C."/>
<person name="O'Brien R."/>
<person name="Bibel M."/>
<person name="Schiess R."/>
<person name="Aebersold R."/>
<person name="Watts J.D."/>
</authorList>
<dbReference type="PubMed" id="19349973"/>
<dbReference type="DOI" id="10.1038/nbt.1532"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-58; ASN-110 AND ASN-313</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-495</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2013" name="Cell Rep." volume="5" first="180" last="193">
<title>A BRISC-SHMT complex deubiquitinates IFNAR1 and regulates interferon responses.</title>
<authorList>
<person name="Zheng H."/>
<person name="Gupta V."/>
<person name="Patterson-Fortin J."/>
<person name="Bhattacharya S."/>
<person name="Katlinski K."/>
<person name="Wu J."/>
<person name="Varghese B."/>
<person name="Carbone C.J."/>
<person name="Aressy B."/>
<person name="Fuchs S.Y."/>
<person name="Greenberg R.A."/>
</authorList>
<dbReference type="PubMed" id="24075985"/>
<dbReference type="DOI" id="10.1016/j.celrep.2013.08.025"/>
</citation>
<scope>FUNCTION</scope>
<scope>UBIQUITINATION</scope>
<scope>MUTAGENESIS OF SER-535</scope>
<scope>PHOSPHORYLATION AT SER-535</scope>
<scope>INTERACTION WITH SHMT2 AND THE BRISC COMPLEX</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-495</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2011" name="Cell" volume="146" first="621" last="632">
<title>Structural linkage between ligand discrimination and receptor activation by type I interferons.</title>
<authorList>
<person name="Thomas C."/>
<person name="Moraga I."/>
<person name="Levin D."/>
<person name="Krutzik P.O."/>
<person name="Podoplelova Y."/>
<person name="Trejo A."/>
<person name="Lee C."/>
<person name="Yarden G."/>
<person name="Vleck S.E."/>
<person name="Glenn J.S."/>
<person name="Nolan G.P."/>
<person name="Piehler J."/>
<person name="Schreiber G."/>
<person name="Garcia K.C."/>
</authorList>
<dbReference type="PubMed" id="21854986"/>
<dbReference type="DOI" id="10.1016/j.cell.2011.06.048"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 30-332 IN COMPLEX WITH IFNAR2; IFNA2 AND IFNW1</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-172</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="443" last="448">
<title>Structural basis of recognition of interferon-alpha receptor by tyrosine kinase 2.</title>
<authorList>
<person name="Wallweber H.J."/>
<person name="Tam C."/>
<person name="Franke Y."/>
<person name="Starovasnik M.A."/>
<person name="Lupardus P.J."/>
</authorList>
<dbReference type="PubMed" id="24704786"/>
<dbReference type="DOI" id="10.1038/nsmb.2807"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.99 ANGSTROMS) OF 478-507 IN COMPLEX WITH TYK2</scope>
<scope>INTERACTION WITH TYK2</scope>
<scope>MUTAGENESIS OF 491-LEU-LEU-492; 496-GLU-GLU-497 AND GLU-500</scope>
</reference>
<comment type="function">
<text evidence="6 9 11 12 15 16 21 31">Component of the receptor for type I interferons, including interferons alpha, IFNB1 and IFNW1 (PubMed:2153461, PubMed:7665574, PubMed:10049744, PubMed:14532120, PubMed:15337770, PubMed:21854986). Functions in general as heterodimer with IFNAR2 (PubMed:7665574, PubMed:10049744, PubMed:21854986). Type I interferon binding activates the JAK-STAT signaling cascade, and triggers tyrosine phosphorylation of a number of proteins including JAKs, TYK2, STAT proteins and the IFNR alpha- and beta-subunits themselves (PubMed:7665574, PubMed:21854986). Can form an active IFNB1 receptor by itself and activate a signaling cascade that does not involve activation of the JAK-STAT pathway (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="9 11 12 13 17 18 19 20 21 23">Heterodimer with IFNAR2 (PubMed:7665574, PubMed:10049744, PubMed:21854986). Interacts with STAT1 and STAT2; the interaction requires its phosphorylation at Tyr-466 (PubMed:9121453). Interacts with TYK2 (PubMed:7526154, PubMed:15337770, PubMed:24704786). Interacts (serine-phosphorylated form) with FBXW11, the substrate recognition component of a SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex (PubMed:14532120, PubMed:15337770, PubMed:18056411). Interacts with SHMT2; this promotes interaction with ABRAXAS2 and the BRISC complex (PubMed:24075985).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1547250">
<id>P17181</id>
</interactant>
<interactant intactId="EBI-355189">
<id>Q9UKB1</id>
<label>FBXW11</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1547250">
<id>P17181</id>
</interactant>
<interactant intactId="EBI-3267258">
<id>Q86VI4</id>
<label>LAPTM4B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1547250">
<id>P17181</id>
</interactant>
<interactant intactId="EBI-1057697">
<id>P42224</id>
<label>STAT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1547250">
<id>P17181</id>
</interactant>
<interactant intactId="EBI-1546963">
<id>P52630</id>
<label>STAT2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-16099379">
<id>P17181-1</id>
</interactant>
<interactant intactId="EBI-1383454">
<id>P29597</id>
<label>TYK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<molecule>Isoform 1</molecule>
<subcellularLocation>
<location evidence="11 13 16 33">Cell membrane</location>
<topology evidence="28">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="13 29">Late endosome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="13 29">Lysosome</location>
</subcellularLocation>
<text evidence="11 13">Interferon binding triggers internalization of the receptor from the cell membrane into endosomes and then into lysosomes.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P17181-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P17181-2</id>
<name>2</name>
<name>Sol-1</name>
<name>Soluble form 1</name>
<sequence type="described" ref="VSP_029930 VSP_029931"/>
</isoform>
<isoform>
<id>P17181-3</id>
<name>3</name>
<name>Sol-2</name>
<name>Soluble form 2</name>
<sequence type="described" ref="VSP_029928 VSP_029929"/>
</isoform>
<isoform>
<id>P17181-4</id>
<name>4</name>
<sequence type="described" ref="VSP_055322"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="22">IFN receptors are present in all tissues and even on the surface of most IFN-resistant cells. Isoform 1, isoform 2 and isoform 3 are expressed in the IFN-alpha sensitive myeloma cell line U266B1. Isoform 2 and isoform 3 are expressed in the IFN-alpha resistant myeloma cell line U266R. Isoform 1 is not expressed in IFN-alpha resistant myeloma cell line U266R.</text>
</comment>
<comment type="PTM">
<text evidence="11 12 13 18">Ubiquitinated, leading to its internalization and degradation (PubMed:14532120, PubMed:15337770). Polyubiquitinated via 'Lys-48'-linked and 'Lys-63'-linked ubiquitin chains, leading to receptor internalization and lysosomal degradation (PubMed:18056411). The 'Lys-63'-linked ubiquitin chains are cleaved off by the BRISC complex (PubMed:24075985).</text>
</comment>
<comment type="PTM">
<text evidence="9 11 12 20">Phosphorylated on serine residues in response to interferon binding; this promotes interaction with FBXW11 and ubiquitination (PubMed:14532120, PubMed:15337770, PubMed:24075985). Phosphorylated on tyrosine residues by TYK2 tyrosine kinase (PubMed:7526154). Phosphorylated on tyrosine residues in response to interferon (PubMed:10049744).</text>
</comment>
<comment type="PTM">
<text evidence="15">Palmitoylation at Cys-463 is required for the activation of STAT1 and STAT2.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 2</molecule>
<text evidence="28">Incomplete sequence.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 3</molecule>
<text evidence="28">Incomplete sequence.</text>
</comment>
<comment type="similarity">
<text evidence="28">Belongs to the type II cytokine receptor family.</text>
</comment>
<comment type="sequence caution" evidence="28">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="AAH02590" version="1"/>
</conflict>
<text>Contaminating sequence. Potential poly-A sequence.</text>
</comment>
<comment type="online information" name="SeattleSNPs">
<link uri="http://pga.gs.washington.edu/data/ifnar1/"/>
</comment>
<dbReference type="EMBL" id="J03171">
<property type="protein sequence ID" value="AAA52730.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X60459">
<property type="protein sequence ID" value="CAA42992.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK298051">
<property type="protein sequence ID" value="BAG60345.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK312631">
<property type="protein sequence ID" value="BAG35516.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK222770">
<property type="protein sequence ID" value="BAD96490.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK222812">
<property type="protein sequence ID" value="BAD96532.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY654286">
<property type="protein sequence ID" value="AAT49100.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF039907">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP000296">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP000297">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP000298">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471079">
<property type="protein sequence ID" value="EAX09837.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471079">
<property type="protein sequence ID" value="EAX09839.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC002590">
<property type="protein sequence ID" value="AAH02590.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC021825">
<property type="protein sequence ID" value="AAH21825.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS13624.1">
<molecule id="P17181-1"/>
</dbReference>
<dbReference type="PIR" id="A32694">
<property type="entry name" value="A32694"/>
</dbReference>
<dbReference type="PIR" id="S41602">
<property type="entry name" value="S41602"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000620.2">
<molecule id="P17181-1"/>
<property type="nucleotide sequence ID" value="NM_000629.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005261021.1">
<molecule id="P17181-4"/>
<property type="nucleotide sequence ID" value="XM_005260964.2"/>
</dbReference>
<dbReference type="PDB" id="3S98">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=30-332"/>
</dbReference>
<dbReference type="PDB" id="3SE3">
<property type="method" value="X-ray"/>
<property type="resolution" value="4.00"/>
<property type="chains" value="A=28-436"/>
</dbReference>
<dbReference type="PDB" id="3SE4">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="A=28-436"/>
</dbReference>
<dbReference type="PDB" id="4PO6">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.99"/>
<property type="chains" value="B=478-507"/>
</dbReference>
<dbReference type="PDBsum" id="3S98"/>
<dbReference type="PDBsum" id="3SE3"/>
<dbReference type="PDBsum" id="3SE4"/>
<dbReference type="PDBsum" id="4PO6"/>
<dbReference type="SMR" id="P17181"/>
<dbReference type="BioGRID" id="109676">
<property type="interactions" value="30"/>
</dbReference>
<dbReference type="CORUM" id="P17181"/>
<dbReference type="DIP" id="DIP-57N"/>
<dbReference type="ELM" id="P17181"/>
<dbReference type="IntAct" id="P17181">
<property type="interactions" value="13"/>
</dbReference>
<dbReference type="MINT" id="P17181"/>
<dbReference type="STRING" id="9606.ENSP00000270139"/>
<dbReference type="BindingDB" id="P17181"/>
<dbReference type="ChEMBL" id="CHEMBL1887"/>
<dbReference type="DrugBank" id="DB14999">
<property type="generic name" value="Human interferon beta"/>
</dbReference>
<dbReference type="DrugBank" id="DB05258">
<property type="generic name" value="Interferon alfa"/>
</dbReference>
<dbReference type="DrugBank" id="DB00034">
<property type="generic name" value="Interferon alfa-2a, Recombinant"/>
</dbReference>
<dbReference type="DrugBank" id="DB00105">
<property type="generic name" value="Interferon alfa-2b"/>
</dbReference>
<dbReference type="DrugBank" id="DB00011">
<property type="generic name" value="Interferon alfa-n1"/>
</dbReference>
<dbReference type="DrugBank" id="DB00018">
<property type="generic name" value="Interferon alfa-n3"/>
</dbReference>
<dbReference type="DrugBank" id="DB00069">
<property type="generic name" value="Interferon alfacon-1"/>
</dbReference>
<dbReference type="DrugBank" id="DB00060">
<property type="generic name" value="Interferon beta-1a"/>
</dbReference>
<dbReference type="DrugBank" id="DB00068">
<property type="generic name" value="Interferon beta-1b"/>
</dbReference>
<dbReference type="DrugBank" id="DB05472">
<property type="generic name" value="omega interferon"/>
</dbReference>
<dbReference type="DrugBank" id="DB00008">
<property type="generic name" value="Peginterferon alfa-2a"/>
</dbReference>
<dbReference type="DrugBank" id="DB00022">
<property type="generic name" value="Peginterferon alfa-2b"/>
</dbReference>
<dbReference type="DrugCentral" id="P17181"/>
<dbReference type="GuidetoPHARMACOLOGY" id="1723"/>
<dbReference type="TCDB" id="8.A.132.1.1">
<property type="family name" value="the interferon/interleukin receptor (iir) family"/>
</dbReference>
<dbReference type="GlyConnect" id="1946">
<property type="glycosylation" value="8 N-Linked glycans (6 sites)"/>
</dbReference>
<dbReference type="GlyGen" id="P17181">
<property type="glycosylation" value="12 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="P17181"/>
<dbReference type="PhosphoSitePlus" id="P17181"/>
<dbReference type="SwissPalm" id="P17181"/>
<dbReference type="BioMuta" id="IFNAR1"/>
<dbReference type="DMDM" id="90110827"/>
<dbReference type="jPOST" id="P17181"/>
<dbReference type="MassIVE" id="P17181"/>
<dbReference type="MaxQB" id="P17181"/>
<dbReference type="PaxDb" id="P17181"/>
<dbReference type="PeptideAtlas" id="P17181"/>
<dbReference type="PRIDE" id="P17181"/>
<dbReference type="ProteomicsDB" id="4722"/>
<dbReference type="ProteomicsDB" id="53460">
<molecule id="P17181-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="53461">
<molecule id="P17181-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="53462">
<molecule id="P17181-3"/>
</dbReference>
<dbReference type="ABCD" id="P17181">
<property type="antibodies" value="19 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="3016">
<property type="antibodies" value="785 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="3454"/>
<dbReference type="Ensembl" id="ENST00000270139">
<molecule id="P17181-1"/>
<property type="protein sequence ID" value="ENSP00000270139"/>
<property type="gene ID" value="ENSG00000142166"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000652450">
<molecule id="P17181-4"/>
<property type="protein sequence ID" value="ENSP00000498654"/>
<property type="gene ID" value="ENSG00000142166"/>
</dbReference>
<dbReference type="GeneID" id="3454"/>
<dbReference type="KEGG" id="hsa:3454"/>
<dbReference type="UCSC" id="uc002yrn.4">
<molecule id="P17181-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="3454"/>
<dbReference type="DisGeNET" id="3454"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000142166.12"/>
<dbReference type="GeneCards" id="IFNAR1"/>
<dbReference type="HGNC" id="HGNC:5432">
<property type="gene designation" value="IFNAR1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000142166">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="107450">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P17181"/>
<dbReference type="OpenTargets" id="ENSG00000142166"/>
<dbReference type="PharmGKB" id="PA29670"/>
<dbReference type="eggNOG" id="ENOG502RISU">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000158406"/>
<dbReference type="HOGENOM" id="CLU_035134_0_0_1"/>
<dbReference type="InParanoid" id="P17181"/>
<dbReference type="KO" id="K05130"/>
<dbReference type="OMA" id="KLPGCQH"/>
<dbReference type="OrthoDB" id="941128at2759"/>
<dbReference type="PhylomeDB" id="P17181"/>
<dbReference type="PathwayCommons" id="P17181"/>
<dbReference type="Reactome" id="R-HSA-909733">
<property type="pathway name" value="Interferon alpha/beta signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-912694">
<property type="pathway name" value="Regulation of IFNA signaling"/>
</dbReference>
<dbReference type="SignaLink" id="P17181"/>
<dbReference type="SIGNOR" id="P17181"/>
<dbReference type="BioGRID-ORCS" id="3454">
<property type="hits" value="6 hits in 874 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="IFNAR1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P17181"/>
<dbReference type="GeneWiki" id="IFNAR1"/>
<dbReference type="GenomeRNAi" id="3454"/>
<dbReference type="Pharos" id="P17181">
<property type="development level" value="Tclin"/>
</dbReference>
<dbReference type="PRO" id="PR:P17181"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 21"/>
</dbReference>
<dbReference type="RNAct" id="P17181">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000142166">
<property type="expression patterns" value="Expressed in monocyte and 215 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P17181">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P17181">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005770">
<property type="term" value="C:late endosome"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005764">
<property type="term" value="C:lysosome"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0004896">
<property type="term" value="F:cytokine receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0019962">
<property type="term" value="F:type I interferon binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004905">
<property type="term" value="F:type I interferon receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035457">
<property type="term" value="P:cellular response to interferon-alpha"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007259">
<property type="term" value="P:receptor signaling pathway via JAK-STAT"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0032496">
<property type="term" value="P:response to lipopolysaccharide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009615">
<property type="term" value="P:response to virus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0060337">
<property type="term" value="P:type I interferon signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="5"/>
</dbReference>
<dbReference type="InterPro" id="IPR003961">
<property type="entry name" value="FN3_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036116">
<property type="entry name" value="FN3_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR015373">
<property type="entry name" value="Interferon/interleukin_rcp_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR016669">
<property type="entry name" value="Interferon_alpha/beta_rcpt-1"/>
</dbReference>
<dbReference type="Pfam" id="PF09294">
<property type="entry name" value="Interfer-bind"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF01108">
<property type="entry name" value="Tissue_fac"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF016567">
<property type="entry name" value="IFN_alpha/beta_recept-1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49265">
<property type="entry name" value="SSF49265"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="PROSITE" id="PS50853">
<property type="entry name" value="FN3"/>
<property type="match status" value="4"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0967">Endosome</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0449">Lipoprotein</keyword>
<keyword id="KW-0458">Lysosome</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0564">Palmitate</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="7">
<location>
<begin position="1"/>
<end position="27"/>
</location>
</feature>
<feature type="chain" description="Interferon alpha/beta receptor 1" id="PRO_0000011001">
<location>
<begin position="28"/>
<end position="557"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="7">
<location>
<begin position="28"/>
<end position="436"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="7">
<location>
<begin position="437"/>
<end position="457"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="7">
<location>
<begin position="458"/>
<end position="557"/>
</location>
</feature>
<feature type="domain" description="Fibronectin type-III 1" evidence="8">
<location>
<begin position="32"/>
<end position="126"/>
</location>
</feature>
<feature type="domain" description="Fibronectin type-III 2" evidence="8">
<location>
<begin position="127"/>
<end position="227"/>
</location>
</feature>
<feature type="domain" description="Fibronectin type-III 3" evidence="8">
<location>
<begin position="231"/>
<end position="329"/>
</location>
</feature>
<feature type="domain" description="Fibronectin type-III 4" evidence="8">
<location>
<begin position="331"/>
<end position="432"/>
</location>
</feature>
<feature type="region of interest" description="Important for interaction with TYK2" evidence="19">
<location>
<begin position="491"/>
<end position="500"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by TYK2" evidence="32">
<location>
<position position="466"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by TYK2" evidence="32">
<location>
<position position="481"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 5">
<location>
<position position="495"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 12 13 18">
<location>
<position position="535"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="S-palmitoyl cysteine" evidence="15">
<location>
<position position="463"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="50"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="14">
<location>
<position position="58"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="81"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="88"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="14">
<location>
<position position="110"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 17">
<location>
<position position="172"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="254"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="14">
<location>
<position position="313"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="314"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="376"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="416"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="433"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 17">
<location>
<begin position="79"/>
<end position="87"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 17">
<location>
<begin position="199"/>
<end position="220"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 17">
<location>
<begin position="283"/>
<end position="291"/>
</location>
</feature>
<feature type="disulfide bond" evidence="6">
<location>
<begin position="403"/>
<end position="426"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="30">
<location>
<position position="501"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="30">
<location>
<position position="525"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="30">
<location>
<position position="526"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_055322" evidence="26">
<location>
<begin position="1"/>
<end position="69"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_029928" evidence="27">
<location>
<begin position="414"/>
<end position="421"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_029929" evidence="27">
<location>
<begin position="428"/>
<end position="480"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_029930" evidence="27">
<original>KTKPGNT</original>
<variation>NISLNSH</variation>
<location>
<begin position="428"/>
<end position="434"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_029931" evidence="27">
<location>
<begin position="435"/>
<end position="557"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2257167." id="VAR_002717" evidence="10 16 24">
<original>V</original>
<variation>L</variation>
<location>
<position position="168"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17875833." id="VAR_020502" evidence="25">
<original>V</original>
<variation>I</variation>
<location>
<position position="307"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17875834." id="VAR_020503" evidence="25">
<original>T</original>
<variation>M</variation>
<location>
<position position="359"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs internalization in response to interferon." evidence="13">
<original>Y</original>
<variation>F</variation>
<location>
<position position="466"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs interaction with TYK2." evidence="19">
<original>LL</original>
<variation>AA</variation>
<location>
<begin position="491"/>
<end position="492"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs interaction with TYK2." evidence="19">
<original>EE</original>
<variation>AA</variation>
<location>
<begin position="496"/>
<end position="497"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs interaction with TYK2." evidence="19">
<original>E</original>
<variation>A</variation>
<location>
<position position="500"/>
</location>
</feature>
<feature type="mutagenesis site" description="Mildly reduces ubiquitination. Nearly abolishes ubiquitination and subsequent degradation; when associated with 525-R-R-526." evidence="12">
<original>K</original>
<variation>R</variation>
<location>
<position position="501"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces ubiquitination. Nearly abolishes ubiquitination and subsequent degradation; when associated with R-501." evidence="12">
<original>KK</original>
<variation>RR</variation>
<location>
<begin position="525"/>
<end position="526"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with FBXW11 and decreases ubiquitination." evidence="11 12">
<original>S</original>
<variation>A</variation>
<location>
<position position="535"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation at this site and interaction with SHMT2." evidence="18">
<original>S</original>
<variation>A</variation>
<location>
<position position="535"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with FBXW11 and decreases ubiquitination." evidence="12">
<original>S</original>
<variation>A</variation>
<location>
<position position="539"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA52730." ref="1" evidence="28">
<original>A</original>
<variation>G</variation>
<location>
<position position="17"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BAD96532." ref="4" evidence="28">
<original>V</original>
<variation>M</variation>
<location>
<position position="59"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BAD96532." ref="4" evidence="28">
<original>Q</original>
<variation>R</variation>
<location>
<position position="279"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAG35516." ref="3" evidence="28">
<original>D</original>
<variation>G</variation>
<location>
<position position="344"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BAD96532." ref="4" evidence="28">
<original>D</original>
<variation>N</variation>
<location>
<position position="479"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="37"/>
<end position="41"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="44"/>
<end position="48"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="60"/>
<end position="69"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="80"/>
<end position="88"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="100"/>
<end position="107"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="112"/>
<end position="116"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="122"/>
<end position="125"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="132"/>
<end position="137"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="142"/>
<end position="147"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="164"/>
<end position="171"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="172"/>
<end position="174"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="178"/>
<end position="183"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="186"/>
<end position="189"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="197"/>
<end position="206"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="207"/>
<end position="209"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="219"/>
<end position="222"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="233"/>
<end position="240"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="243"/>
<end position="249"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="251"/>
<end position="254"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="256"/>
<end position="263"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="264"/>
<end position="267"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="281"/>
<end position="283"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="286"/>
<end position="294"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="295"/>
<end position="297"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="300"/>
<end position="310"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="322"/>
<end position="325"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3S98"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3SE3"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3SE4"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P33896"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255"/>
<evidence key="8" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00316"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10049744"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1370833"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14532120"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15337770"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18056411"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19349973"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19561067"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2153461"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21854986"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24075985"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24704786"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7526154"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7665574"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8307198"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9121453"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source ref="4"/>
</evidence>
<evidence key="25" type="ECO:0000269">
<source ref="5"/>
</evidence>
<evidence key="26" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8307198"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000305"/>
<evidence key="29" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="14532120"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="15337770"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="21854986"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="7526154"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="7665574"/>
</source>
</evidence>
<sequence length="557" mass="63525" checksum="24A01779DB7F356F" modified="2006-03-07" version="3" precursor="true">MMVVLLGATTLVLVAVAPWVLSAAAGGKNLKSPQKVEVDIIDDNFILRWNRSDESVGNVTFSFDYQKTGMDNWIKLSGCQNITSTKCNFSSLKLNVYEEIKLRIRAEKENTSSWYEVDSFTPFRKAQIGPPEVHLEAEDKAIVIHISPGTKDSVMWALDGLSFTYSLVIWKNSSGVEERIENIYSRHKIYKLSPETTYCLKVKAALLTSWKIGVYSPVHCIKTTVENELPPPENIEVSVQNQNYVLKWDYTYANMTFQVQWLHAFLKRNPGNHLYKWKQIPDCENVKTTQCVFPQNVFQKGIYLLRVQASDGNNTSFWSEEIKFDTEIQAFLLPPVFNIRSLSDSFHIYIGAPKQSGNTPVIQDYPLIYEIIFWENTSNAERKIIEKKTDVTVPNLKPLTVYCVKARAHTMDEKLNKSSVFSDAVCEKTKPGNTSKIWLIVGICIALFALPFVIYAAKVFLRCINYVFFPSLKPSSSIDEYFSEQPLKNLLLSTSEEQIEKCFIIENISTIATVEETNQTDEDHKKYSSQTSQDSGNYSNEDESESKTSEELQQDFV</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

